MassMutual Ventures’ Post

Welcome to the portfolio, Goodpath! We're excited to share that MMV has led their $18M Series A with participation from Healthy Ventures and current investors. Goodpath delivers whole-person care for chronic conditions, including weight management, musculoskeletal pain, diabetes, digestive health, sleep, mental health, and cancer survivorship. Through clinical treatment and dedicated coaching provided by a multi-disciplinary care team, Goodpath substantially reduces current year employee healthcare claims and delivers a guaranteed ROI for employers and payors. "Chronic and mental health conditions account for the vast majority of U.S. healthcare costs, and yet the way care is delivered has lagged behind. We believe the next generation of category leaders will be those that deliver this combination of scale, precision, and measurable cost impact in a single model," said MMV's Eric Emmons. "What excites us about Goodpath is that it is already demonstrating that combination: high engagement across large populations, predictive use of data and outcomes that show up directly in claims. That alignment of clinical credibility and financial impact points to how chronic care will be financed and delivered over the next decade." Congrats Bill Gianoukos, Akl Fahed, and the entire Goodpath team! 🚀 https://lnkd.in/gFTz6JjU. #vc #venturecapital #startup #startups #healthtech #healthtechinnovation Mark Goodman Samantha Santaniello-Lawrence